• By ICR Secretariat
  • Posted Thursday, May 27, 2021

GlaxoSmithKline dumps entire stake in respiratory partner Innoviva for $392M

https://www.fiercepharma.com/pharma/gsk-dumps-entire-stake-respiratory-treatment-partner-innoviva-for-392m

As GSK forges ahead with its plan to split into two by next year, the pharma giant has unveiled plans to sell its entire stake in respiratory drug partner Innoviva for roughly $392 million.